Quantcast

Latest Cytoskeleton Stories

6be016993c239b8653314df00e690f17
2009-01-05 10:28:03

Possible mechanism of muscle denervation in Emery-Dreifuss muscular dystrophy Mutations in the nuclear intermediate filament lamin A/C (LMNA) gene are associated with Emery-Dreifuss muscular dystrophy, but cause the disease by unknown mechanisms. M©jat et al. show that one mechanism involves the disruption of neuromuscular junctions. The study will appear online on Monday, January 5, 2009 and in the January 12, 2009 print issue of the Journal of Cell Biology. Muscle fiber cells contain...

d1c0bd59c69804e522f308cc1a39487e1
2008-12-09 10:19:28

Researchers from the Ludwig Institute for Cancer Research at the University of California, San Diego School of Medicine have identified a key step required for cell division in a study that could help improve therapies to treat cancer. Their work describing the mechanism of the contractile ring "“ a structure that pinches the mother cell into two daughter cells "“ has been published in the December 5 issue of the journal Science. The division of one cell into two is accomplished...

c69d551e61ab3d5c23dceb68bd67f44a1
2008-11-25 11:40:00

Flip open any biology textbook and you're bound to see a complicated diagram of the inner workings of a cell, with its internal scaffolding, the  cytoskeleton, and how it maintains a cell's shape. Yet the fundamental question remains, which came first: the shape, or the skeleton?Now a research team led by Phong Tran, PhD, Assistant Professor of Cell and Developmental Biology at the University of Pennsylvania School of Medicine, has the answer: Both.The findings, published online this...

2008-10-23 18:00:25

Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that it is scheduled to report third quarter results on Thursday, October 30, 2008 at 4:00 p.m. Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 p.m. Eastern Time to discuss operational and financial results and the company's outlook for the future. The conference call will be simultaneously webcast and can be accessed in the Investor Relations section of Cytokinetics'...

2008-10-15 09:00:47

AVI BioPharma has announced that the European Medicines Agency Committee for Orphan Medicinal Products adopted a positive opinion recommending orphan medicinal product designation for AVI-4658 to treat Duchenne muscular dystrophy. The company believes the positive opinion of the Committee for Orphan Medicinal Products (COMP) will serve as the scientific basis for the European Commission to issue a EU orphan designation pursuant to Regulation (ED) 141/2000. Additionally, AVI BioPharma...

2008-09-30 18:01:16

Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the Third Annual JMP Securities Healthcare Focus Conference on Tuesday, October 7, 2008, at 9:30 a.m. Eastern Time at the Le Parker Meridian Hotel, New York, New York. Interested parties may access the live audio webcast of these presentations and replays by visiting the Investors Relations section of the Cytokinetics website at...

2008-09-22 09:00:58

AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that Dr. Leslie Hudson, AVI's President and CEO, will present an update on the continuing transition of AVI from an antisense pioneer into a leading discoverer and developer of RNA-based drugs. The corporate overview will include an update on AVI's Duchenne muscular dystrophy program (DMD), its biodefense projects (which include significant data from the Company's ongoing Ebola and Marburg virus programs in...

2008-08-28 18:00:51

Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the Thomson Reuters and BioCentury NewsMakers in the Biotechnology Industry Conference on Thursday, September 4, 2008, at 9:00 a.m. Eastern Time at the Millennium Broadway Hotel, New York, New York. Interested parties may access the live audio webcast of these presentations and replays by visiting the Investors Relations section...

2008-07-24 18:01:00

Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that it will report second quarter results on Thursday, July 31, 2008 at 4:00 p.m. Eastern Time. Following the announcement, Cytokinetics' senior management will host a conference call at 4:30 p.m. Eastern Time to discuss operational and financial results and the company's outlook for the future. The conference call will be simultaneously webcast and can be accessed in the Investor Relations section of Cytokinetics' website at...

2008-06-27 06:02:23

By Dinh, Anh-Tuan Pangarkar, Chinmay; Mitragotri, Samir Unlike macroscopic problems in mass, energy and momentum transfer, which are described by continuum equations, the movements and interactions of the nanoscale entities within a cell constitute a transport phenomenon known as discrete nanoscale transport (DNT). Imagine yourself on an alien spaceship, watching the daily goings- on of a large city through a telescope. You would see (among other things) complex transportation systems...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related